The role of acetaldehyde in the actions of alcohol (Update 2000)

被引:214
作者
Eriksson, CJP [1 ]
机构
[1] Natl Publ Hlth Inst, Dept Mental Hlth & Alcohol Res, Helsinki 00101, Finland
关键词
acetaldehyde; alcohol drinking; flushing; cirrhosis; cancer;
D O I
10.1111/j.1530-0277.2001.tb02369.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Recent advances in the field of acetaldehyde (AcH) research have raised the need for a comprehensive review on the role of AcH in the actions of alcohol. This update is an attempt to summarize the available AcH research. Methods: The descriptive part of this article covers not only recent research but also the development of the field. Special emphasis is placed on mechanistic analyses, near hypotheses, and conclusions. Results: Elevated AcH during alcohol intoxication causes alcohol sensitivity, which involves vasodilation associated with increased skin temperature, subjective feelings of hotness and facial flushing, increased heart and respiration rate, lowered blood pressure, sensation of dry mouth or throat associated with bronchoconstriction and allergy reactions, nausea and headache, and also reinforcing reactions like euphoria. These effects seem to involve catecholamine, opiate peptide, prostaglandin, histamine, and/or kinin mechanisms. The contribution of AcH to the pathological consequences of chronic alcohol intake is well established for different forms of cancer in the digestive tract and the upper airways. AcH seems to play a role in the etiology of liver cirrhosis. AcH may have a role in other pathological developments, which include brain damage, cardiomyopathy, pancreatitis, and fetal alcohol syndrome. AcH creates both unpleasant aversive reactions that protect against excessive alcohol drinking and euphoric sensations that may reinforce alcohol drinking. The protective effect of AcH may be used in future treatments that involve gene therapy with or without liver transplantation. Conclusions: AcH plays a role in most of the actions of alcohol The individual variability in these AcH-mediated actions will depend on the genetic polymorphism, not only for the alcohol and AcH-metabolizing enzymes but also for the target sites for AcH actions. The subtle balance between aversive and reinforcing, protecting and promoting factors will determine the overall behavioral and pathological developments.
引用
收藏
页码:15S / 32S
页数:18
相关论文
共 310 条
  • [81] A liver nuclear ethanol metabolizing system.: Formation of metabolites that bind covalently to macromolecules and lipids
    Gómez, MID
    Fanelli, SL
    Castro, GD
    Costantini, MH
    Castro, JA
    [J]. TOXICOLOGY, 1999, 138 (01) : 19 - 28
  • [82] Acetaldehyde-mediated collagen regulation in hepatic stellate cells
    Greenwel, P
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1999, 23 (05) : 930 - 933
  • [83] Guyton AC., 1996, TXB MED PHYSL
  • [84] Metabolism of ethanol by rat pancreatic acinar cells
    Haber, PS
    Apte, MV
    Applegate, TL
    Norton, ID
    Korsten, MA
    Pirola, RC
    Wilson, JS
    [J]. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1998, 132 (04): : 294 - 302
  • [85] HALD J, 1948, ACTA PHARMACOL TOX, V4, P285
  • [86] HARADA S, 1981, LANCET, V2, P982
  • [87] Harada Shoji, 1993, Japanese Journal of Alcohol Studies and Drug Dependence, V28, P400
  • [88] CIRCULATING ANTIBODIES TO CARDIAC PROTEIN-ACETALDEHYDE ADDUCTS IN ALCOHOLIC HEART-MUSCLE DISEASE
    HARCOMBE, AA
    RAMSAY, L
    KENNA, JG
    KOSKINAS, J
    WHY, HJF
    RICHARDSON, PJ
    WEISSBERG, PL
    ALEXANDER, GJM
    [J]. CLINICAL SCIENCE, 1995, 88 (03) : 263 - 268
  • [89] Co-metabolism of ethanol, ethanol-derived acetaldehyde, and 4-hydroxynonenal in isolated rat hepatocytes
    Hartley, DP
    Petersen, DR
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1997, 21 (02) : 298 - 304
  • [90] Alcohol dehydrogenase 3 genotype and risk of oral cavity and pharyngeal cancers
    Harty, LC
    Caporaso, NE
    Hayes, RB
    Winn, DM
    BravoOtero, E
    Blot, WJ
    Kleinman, DV
    Brown, LM
    Armenian, HK
    Fraumeni, JF
    Shields, PG
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (22): : 1698 - 1705